Munafa Stock Market Course + Intraday & FNO calls 
Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Supernus Pharmaceuticals (SUPN)
Technical Analysis Report for USA stock SUPN Supernus Pharmaceuticals. Dated: 06 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SUPN Supernus Pharmaceuticals then click here. or read Experts views on Supernus Pharmaceuticals or Forecast & share price targets of Supernus Pharmaceuticals
Supernus Pharmaceuticals Opened at 47.82 and Closed at: 46.76, which is -0.32% of previous session's close. It moved within a range of 46.55 and 48.40
The session was a Bearish session with an average volume of 1344800, which is -24.32% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Dead cross was found 3 days back on mid term averages
Support for tomorrow is 45.73 and resistance for tomorrow is 47.58
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 46.07, 45.39 resistance for tomorrow's hourly charts is 47.92, 49.09
10 Day SMA for Supernus Pharmaceuticals (SUPN) is 46.06 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Supernus Pharmaceuticals (SUPN) is 46.71 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Supernus Pharmaceuticals (SUPN) is 46.15 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 47.99 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Supernus Pharmaceuticals is 48.91 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Supernus Pharmaceuticals is at 46.71 and 200 DMA is at 48.91, while 50 DMA and 100 DMA are at 46.15 and 47.99 respectively
Supernus Pharmaceuticals (SUPN) moving average of 20 SMA is at 46.71 and 20 EMA is at 46.43
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Thu Aug | 46.76 | 46.71 | 46.43 |
| 05 Wed Aug | 46.91 | 46.8 | 46.39 |
| 04 Tue Aug | 43.25 | 46.89 | 46.34 |
| 03 Mon Aug | 46.00 | 47.25 | 46.66 |
| 31 Fri Jul | 44.63 | 47.35 | 46.73 |
| 30 Thu Jul | 45.61 | 47.48 | 46.95 |
Supernus Pharmaceuticals (SUPN) moving average of 50 SMA is at 46.15 and 50 EMA is at 46.88
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Thu Aug | 46.76 | 46.15 | 46.88 |
| 05 Wed Aug | 46.91 | 46.15 | 46.89 |
| 04 Tue Aug | 43.25 | 46.16 | 46.89 |
| 03 Mon Aug | 46.00 | 46.26 | 47.04 |
| 31 Fri Jul | 44.63 | 46.33 | 47.08 |
| 30 Thu Jul | 45.61 | 46.41 | 47.18 |
Supernus Pharmaceuticals (SUPN) moving average of 100 SMA is at 47.99 and 100 EMA is at 47.56
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Thu Aug | 46.76 | 47.99 | 47.56 |
| 05 Wed Aug | 46.91 | 48.03 | 47.58 |
| 04 Tue Aug | 43.25 | 48.06 | 47.59 |
| 03 Mon Aug | 46.00 | 48.13 | 47.68 |
| 31 Fri Jul | 44.63 | 48.2 | 47.71 |
| 30 Thu Jul | 45.61 | 48.3 | 47.77 |
Supernus Pharmaceuticals (SUPN) moving average of 200 SMA is at 48.91 and 200 EMA is at 46.79
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Thu Aug | 46.76 | 48.91 | 46.79 |
| 05 Wed Aug | 46.91 | 48.93 | 46.79 |
| 04 Tue Aug | 43.25 | 48.95 | 46.79 |
| 03 Mon Aug | 46.00 | 48.98 | 46.83 |
| 31 Fri Jul | 44.63 | 49 | 46.84 |
| 30 Thu Jul | 45.61 | 49.02 | 46.86 |
Pfizer Inc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Pfizer Inc, about 8.28% more returns!
Laboratory Corporation has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Laboratory Corporation, about 15.65% more returns!
Supernus Pharmaceuticals has performed better than Edwards Lifesciences in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Elanco Animal in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Davita Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Viking Therapeutics in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Rhythm Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 5.54% more returns!
Radnet Inc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Radnet Inc, about 8.91% more returns!
Protagonist Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Protagonist Therapeutics, about 13.79% more returns!
Supernus Pharmaceuticals has performed better than Prothena Corporation in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Novocure in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Moleculin Biotech in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Kamada has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Kamada, about 0.83% more returns!
Iovance Biotherapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 54.22% more returns!
Supernus Pharmaceuticals has performed better than Enanta Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Corvus Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Alphatec Holdings in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Argenx Se has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Argenx Se, about 1.14% more returns!
Supernus Pharmaceuticals Technical analysis of indicators
Price action analysis of Supernus Pharmaceuticals (SUPN) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Supernus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Supernus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 45.53 and Supernus Pharmaceuticals SUPN stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Supernus Pharmaceuticals SUPN stock. Volume based technical analysis of Supernus Pharmaceuticals SUPN stock is negative.
Supernus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SUPN Supernus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SUPN Experts View which covers a lot of information including buying and selling signals
SUPN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Supernus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
